A catch-up validation study on reconstructed human epidermis (SkinEthic™ RHE) for full replacement of the Draize skin irritation test

Bell, 1981, Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness, Science, 211, 1051, 10.1126/science.7008197 Boelsma, 2000, Characterization and comparison of reconstructed skin models: morphological and immunohistochemical evaluation, Acta Dermato-Venereologica, 80, 82 Cannon, 1994, New epidermal model for dermal irritancy testing, Toxicology In Vitro, 8, 889, 10.1016/0887-2333(94)90095-7 Coquette, 1999, Differential expression and release of cytokines by an in vitro reconstituted human epidermis model following skin irritant and sensitizing compounds, Toxicology In Vitro, 13, 867, 10.1016/S0887-2333(99)00076-4 Corsini, 1996, Endogenous interleukin-1 alpha associated with skin irritation induced by tributylin, Toxicology and Applied Pharmacology, 138, 268, 10.1006/taap.1996.0125 Cotovio, 2005, The In Vitro acute skin irritation of chemicals: optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process, ATLA, 33, 329 Cumpstone, 1989, The water permeability of primary mouse keratinocyte cultures grown at the air–liquid interface, Journal of Investigative Dermatology, 92, 598, 10.1111/1523-1747.ep12712043 de Brugerolle de Fraissinette, 1999, Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic®) applied to the testing of topical vehicles, Cell Biology and Toxicology, 15, 121, 10.1023/A:1007577515215 De Wever, 2002, Using tissue engineered skin to evaluate the irritation potential of skin care products, Cosmetics and Toiletries, 117, 28 Dinarello, 1991, Interleukin 1 and interleukin 1 antagonism, Blood, 77, 1627, 10.1182/blood.V77.8.1627.1627 Doucet, 1996, Use of a serum-free reconstituted epidermis as a skin pharmacological model, Toxicology In Vitro, 10, 305, 10.1016/0887-2333(96)00011-2 Draize, 1944, Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes, Journal of Pharmacology and Experimental Therapeutics, 82, 337 ECVAM Scientific Advisory Committee (ESAC) Statement, 2006. Statement on the SkinEthic™ Application of the Skin Human Skin Model for Skin Corrosivity Testing. ESAC 25th Meeting, 16–17 November 2006. Available at: <http://ecvam.jrc.it/index.htm>. ECVAM Scientific Advisory Committee (ESAC) Statement, 2007. Statement on the validity of in-vitro Tests for Skin Irritation. ESAC 26th Meeting, 26–27th April 2007. Available at: <http://ecvam.jrc.it/index.htm>. ECVAM SIVS, May 2007. Performance Standards for Applying Human Skin Models to in vitro Skin Irritation Testing. Available at: <http://ecvam.jrc.it/index.htm>. ECVAM Scientific Advisory Committee (ESAC) Statement, 2008. Statement on the Scientific Validity of in-vitro Tests for Skin Irritation Testing. ESAC 29th Meeting, 4–5th November 2008. Available at: <http://ecvam.jrc.it/index.htm>. El Ghalbzouri, 2008, Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines, Toxicology In Vitro, 22, 1311, 10.1016/j.tiv.2008.03.012 Eskes, 2007, The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals, Alternatives to Animal Testing, 35, 603, 10.1177/026119290703500608 European Commission, 1976. Council Directive 76/768/EEC of 27 July 1976 on the Approximation of the Laws of the Member States Relating to Cosmetic Products. Official Journal of the European Communities L262, 169. European Commission, 2001. Annex VI of the Directive 67/548/ECC. General Classification and Labeling Requirements for Dangerous Substances and Preparations. Official Journal of the European Communities L225, 263–314 (Method B.4 of Annex V to Council Directive 67/548/EEC). European Commission, 2009. Test Method B.46 on Reconstructed Human Epidermis Models (EPISKIN, SKINETHIC, and EPIDERM) for Skin Irritation. EU Test Method Regulation (COM Regulation 440/2008/EC) through the 1st Adaptation to Technical Progress (“ATP”). Fartasch, 1994, Improved barrier structure formation in air-exposed human keratinocyte culture systems, Journal of Investigative Dermatology, 102, 366, 10.1111/1523-1747.ep12371797 Fentem, 2002, ECVAM’s activities in validating alternative tests for skin corrosion and irritation, ATLA, 30, 61 Hoffmann, 2005, Epidermal-skin-test (EST-1000) – a new reconstructed epidermis for in vitro skin corrosivity testing, Toxicology In Vitro, 19, 925, 10.1016/j.tiv.2005.06.010 Hoffmann, 2005, Skin irritation: prevalence, variability, and regulatory classification of existing in vivo data from industrial chemicals, Regulatory Toxicology and Pharmacology, 41, 159, 10.1016/j.yrtph.2004.11.003 Hoffmann, S., 2007. ECVAM Skin Irritation Validation Study Phase II: Analysis of the Primary Endpoint MTT and the Secondary Endpoint IL-1α. Available at: <http://ecvam.jrc.it/index.htm>. Kandárová, H., 2006. Dissertation: Evaluation and Validation of Reconstructed Human Skin Models as Alternatives to Animal Tests in regulatory Toxicology. Free University of Berlin. Kandárová, 2006, Assessment of the human epidermis model SkinEthic RHE for in vitro skin corrosion testing of chemical according to new OECD TG431, Toxicology In Vitro, 20, 547, 10.1016/j.tiv.2005.11.008 Kandárová, 2006, Assessment of the skin irritation potential of chemicals by using the SkinEthic reconstructed human epidermal model and the common skin irritation protocol evaluated in the ECVAM skin irritation study, Alternatives to Laboratory Animals, 34, 393, 10.1177/026119290603400407 Korting, 1994, MTT-assay and neutral red release (NRR)-assay: relative role in the prediction of the irritancy potential of surfactants, Life Sciences, 55, 533, 10.1016/0024-3205(94)00746-2 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, Journal of Immunology Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Niwa, 2009, Evaluation of the skin irritation using a DNA microarray on a reconstructed human epidermal model, Biological and Pharmaceutical Bulletin, 32, 203, 10.1248/bpb.32.203 OECD, 2002. Test Guideline 404. OECD Guideline for the Testing of Chemicals. Acute Dermal Irritation/Corrosion. Updated Guideline, Adopted 24 April 2002. Available at: <http://www.oecd.org/document/22/0,2340,en_2649_34377_1916054_1_1_1_1,00.html>. Ponec, 1988, Lipid composition of cultured keratinocytes in relation to their differentiation, Journal of Lipid Research, 29, 949, 10.1016/S0022-2275(20)38476-5 Poumay, 2004, A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies, Archives of Dermatological Research, 296, 203, 10.1007/s00403-004-0507-y Rosdy, 1990, Terminal epidermal differentiation of human keratinocytes grown in chemically defined medium on inert filter substrates at the air–liquid interface, Journal of Investigative Dermatology, 95, 409, 10.1111/1523-1747.ep12555510 Rosdy, 1993, Production of basement membrane components by a reconstructed epidermis cultured in the absence of serum and dermal factors, Journal of Investigative Dermatology, 129, 227 Spielmann, 2007, The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the skin integrity function test, ATLA, 35, 559 Tinois, 1991, In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute, Experimental Cell Research, 193, 310, 10.1016/0014-4827(91)90102-Z Tornier, 2006, In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols, Toxicology In Vitro, 20, 401, 10.1016/j.tiv.2005.09.004 United Nations Economic Commission for Europe, 2003. The Globally Harmonized System of Classification and Labelling of Chemicals (GHS).UN ST/SG/AC.10/30, United Nations, New York, NY, USA/Geneva, Switzerland: United NationsOrganisation. <http://www.unece.org/trans/danger/publi/ghs> (accessed 15.08.03). Zuang, V., Eskes, C., Worth, A., Cole, T., Hoffman, S., Gallegos Saliner, A., Netzeva, T., Patlewicz, G., Cockshott, A., Gerner, I., 2007. Report from the Chemicals Selection Sub-Committee to the Management Team on Potential Reasons for the Misclassification of Chemicals in the EPISKIN® and EpiDerm® Assays. Available at <http://ecvam.jrc.it/index.htm>.